| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/30/2023 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Annexon, Inc. |
| 05/30/2023 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Annexon, Inc.|
Txns:
| Bought 300,000 shares
@ $2.1324, valued at
$639.7k
|
|
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| Bain Capital Life Sciences Investors, LLC reports a 2.8% stake in Third Harmonic Bio, Inc. |
| 12/05/2022 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Solid Biosciences Inc. |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 09/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/10/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Bought 13,458 shares
@ $9.6206, valued at
$129.5k
Bought 4,011 shares
@ $9.8442, valued at
$39.5k
Bought 21,812 shares
@ $9.5619, valued at
$208.6k
Bought 3,188 shares
@ $10.2378, valued at
$32.6k
|
|
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/05/2021 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.|
Txns:
| Converted 6,999,998 shares
@ $0
Converted 1,334,562 shares
@ $0
Bought 100,000 shares
@ $20, valued at
$2M
Converted 35,000,001 options to buy
@ $0
Converted 6,672,819 options to buy
@ $0 |
|
| 07/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/27/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 3,333,333 shares
@ $3, valued at
$10M
|
|
| 08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/15/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/06/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Converted 2,825,602 shares
@ $0
Converted 859,573 shares
@ $0
Bought 294,117 shares
@ $17, valued at
$5M
Converted 2,825,602 preferred shares
@ $0
Converted 859,573 preferred shares
@ $0 |
|
| 01/30/2020 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Arcutis Biotherapeutics, Inc. |
| 01/16/2020 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Aptinyx Inc. |
| 11/21/2019 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 1,750,000 shares
@ $22.03, valued at
$38.6M
|
|
| 11/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 09/19/2019 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Converted 6,078,103 shares
@ $0
Converted 1,053,204 shares
@ $0
Bought 150,000 shares
@ $18, valued at
$2.7M
Converted 6,078,103 convertible preferred
@ $0
Converted 1,053,204 convertible preferred
@ $0 |
|
|